Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > New corporate presentation

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Sep 26, 2022 9:45pm

126 Views

Post# 34988340

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New corporate presentation

... locating our targets and sending people to the sites presenting the company, signage, cold calls etc all to create exposure now less than a year since the start we have expanded our fleet by over 300 percent the business was cash flow neutral in the first 3 months and now projected to have almost near 7 figur revenues and 6 figures net profit. Yes we did a lot of DD before the start and the level of service is very good but none of those would translate to financial success if not enough folks knew about us!

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments